Literature DB >> 15734717

Regulators of G protein signaling & drugs of abuse.

John R Traynor1, Richard R Neubig.   

Abstract

Drugs of abuse such as opioids and stimulants share a common dopaminergic reward pathway; however, in response to continual intermittent exposure to such drugs, there are neuronal alterations leading to changes in behavior. Regulators of G protein signaling (RGS) are proteins that negatively regulate G protein signaling and are expressed in brain areas important for the pharmacology of abused drugs. Moreover, the level of expression of several of these proteins is regulated by abused drugs. In this article, we discuss RGS proteins, their regulation by morphine and stimulants, and how altered levels of these proteins affect cell signaling to contribute to the pharmacology and behavioral consequence of abused drugs. Finally, we consider if RGS proteins represent viable targets for drug abuse medications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734717     DOI: 10.1124/mi.5.1.7

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  43 in total

1.  Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.

Authors:  David L Roman; Levi L Blazer; C Aaron Monroy; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

2.  RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.

Authors:  Jeffery N Talbot; Emily M Jutkiewicz; Steven M Graves; Crystal F Clemans; Melanie R Nicol; Richard M Mortensen; Xinyan Huang; Richard R Neubig; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

3.  Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors.

Authors:  Ikuo Masuho; Hideko Wakasugi-Masuho; Ekaterina N Posokhova; Joseph R Patton; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

Review 4.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

5.  Sensitivity and kinetics of signal transmission at the first visual synapse differentially impact visually-guided behavior.

Authors:  Ignacio Sarria; Johan Pahlberg; Yan Cao; Alexander V Kolesnikov; Vladimir J Kefalov; Alapakkam P Sampath; Kirill A Martemyanov
Journal:  Elife       Date:  2015-04-16       Impact factor: 8.140

6.  Candidate genes and their regulatory elements: alcohol preference and tolerance.

Authors:  Laura Saba; Sanjiv V Bhave; Nicholas Grahame; Paula Bice; Razvan Lapadat; John Belknap; Paula L Hoffman; Boris Tabakoff
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

7.  A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Authors:  Kassi Psifogeorgou; Kassi Psigfogeorgou; Dimitra Terzi; Maria Martha Papachatzaki; Artemis Varidaki; Deveroux Ferguson; Stephen J Gold; Venetia Zachariou
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

8.  RGS9-2: probing an intracellular modulator of behavior as a drug target.

Authors:  John R Traynor; Dimitra Terzi; Barbara J Caldarone; Venetia Zachariou
Journal:  Trends Pharmacol Sci       Date:  2009-02-09       Impact factor: 14.819

9.  Microfabricated channel array electrophoresis for characterization and screening of enzymes using RGS-G protein interactions as a model system.

Authors:  Jian Pei; John F Dishinger; David L Roman; Chetwana Rungwanitcha; Richard R Neubig; Robert T Kennedy
Journal:  Anal Chem       Date:  2008-05-09       Impact factor: 6.986

10.  Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction.

Authors:  David L Roman; John R Traynor
Journal:  J Med Chem       Date:  2011-09-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.